Literature DB >> 23729366

CCN2: a mechanosignaling sensor modulating integrin-dependent connective tissue remodeling in fibroblasts?

Andrew Leask1.   

Abstract

Tensegrity (tensional integrity) is an emerging concept governing the structure of the body. Integrin-mediated mechanical tension is essential for connective tissue function in vivo. For example, in adult skin fibroblasts, the integrin β1 subunit mediates adhesion to collagen and fibronectin. Moreover, integrin β1, through its abilities to activate latent TGFβ1 and promote collagen production through focal adhesion kinase/rac1/nicotinamide adenine dinucleotide phosphate oxidase (NOX)/reactive oxygen species (ROS), is essential for dermal homeostasis, repair and fibrosis. The integrin β1-interacting protein CCN2, a member of the CCN family of proteins, is induced by TGFβ1; yet, CCN2 is not a simple downstream mediator of TGFβ1, but instead synergistically promote TGFβ1-induced adhesive signaling and fibrosis. Due to its selective ability to sense mechanical forces in the microenvironment, CCN2 may represent an exquisitely precise target for therapeutic intervention.

Entities:  

Year:  2013        PMID: 23729366      PMCID: PMC3709048          DOI: 10.1007/s12079-013-0205-7

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  33 in total

1.  The fibroblast integrin alpha11beta1 is induced in a mechanosensitive manner involving activin A and regulates myofibroblast differentiation.

Authors:  Sergio Carracedo; Ning Lu; Svetlana N Popova; Roland Jonsson; Beate Eckes; Donald Gullberg
Journal:  J Biol Chem       Date:  2010-02-02       Impact factor: 5.157

2.  Possible strategies for anti-fibrotic drug intervention in scleroderma.

Authors:  Andrew Leask
Journal:  J Cell Commun Signal       Date:  2011-01-29       Impact factor: 5.782

3.  Connective tissue growth factor (CCN2) in rat pancreatic stellate cell function: integrin alpha5beta1 as a novel CCN2 receptor.

Authors:  Runping Gao; David R Brigstock
Journal:  Gastroenterology       Date:  2005-09       Impact factor: 22.682

4.  The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts.

Authors:  P D Arora; N Narani; C A McCulloch
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

5.  Matrix contraction by dermal fibroblasts requires transforming growth factor-beta/activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: insights into pathological scarring in chronic fibrotic disease.

Authors:  Yunliang Chen; Xu Shi-Wen; Jonathan van Beek; Laura Kennedy; Marilyn McLeod; Elisabetta A Renzoni; George Bou-Gharios; Sarah Wilcox-Adelman; Paul F Goetinck; Mark Eastwood; Carol M Black; David J Abraham; Andrew Leask
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

6.  Tissue stiffness, latent TGF-beta1 activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis.

Authors:  Boris Hinz
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

7.  Loss of beta1 integrin in mouse fibroblasts results in resistance to skin scleroderma in a mouse model.

Authors:  Shangxi Liu; Mohit Kapoor; Christopher P Denton; David J Abraham; Andrew Leask
Journal:  Arthritis Rheum       Date:  2009-09

8.  Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair.

Authors:  A Igarashi; H Okochi; D M Bradham; G R Grotendorst
Journal:  Mol Biol Cell       Date:  1993-06       Impact factor: 4.138

9.  Connective tissue growth factor is induced in bleomycin-induced skin scleroderma.

Authors:  Shangxi Liu; Reza Taghavi; Andrew Leask
Journal:  J Cell Commun Signal       Date:  2009-11-15       Impact factor: 5.782

Review 10.  Integrin β1: A Mechanosignaling Sensor Essential for Connective Tissue Deposition by Fibroblasts.

Authors:  Andrew Leask
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-05       Impact factor: 4.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.